Tag: HEA MTC PHA MNH

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsHEA MTC PHA MNH

MindHYVE.ai™ Launches Immersive New Website Showcasing the Future of Human-Aligned AGI

Ignored and Undiagnosed: Sleep Apnea Threatens Women’s Cognitive Health

Premium Service Brands Expands National Footprint with 31 New Units, Innovative Service Additions

Tag: HEA MTC PHA MNH

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us